We have located links that may give you full text access.
Case Reports
Journal Article
Central serous chorioretinopathy in endogenous hypercortisolism.
Archives of Ophthalmology 1993 September
OBJECTIVE: To examine the potential association of central serous chorioretinopathy with endogenous hypercortisolism (Cushing's syndrome).
DESIGN: Ophthalmologic survey of consecutively admitted patients with endogenous Cushing's syndrome.
SETTING: An eye clinic of a research center (National Eye Institute, Bethesda, Md).
PATIENTS: Sixty consecutive patients with confirmed endogenous Cushing's syndrome.
MAIN OUTCOME MEASURES: Findings from complete ophthalmologic evaluation.
RESULTS: Three (5%) of 60 patients had one or more episodes of appropriately documented central serous chorioretinopathy. In all cases, the episodes occurred during the period of hypercortisolism.
CONCLUSIONS: Central serous chorioretinopathy is an uncommon manifestation of endogenous Cushing's syndrome. Since central serous chorioretinopathy has been associated with other hypercortisolemic states, we suggest that glucocorticoids may play a role in the development of this disease.
DESIGN: Ophthalmologic survey of consecutively admitted patients with endogenous Cushing's syndrome.
SETTING: An eye clinic of a research center (National Eye Institute, Bethesda, Md).
PATIENTS: Sixty consecutive patients with confirmed endogenous Cushing's syndrome.
MAIN OUTCOME MEASURES: Findings from complete ophthalmologic evaluation.
RESULTS: Three (5%) of 60 patients had one or more episodes of appropriately documented central serous chorioretinopathy. In all cases, the episodes occurred during the period of hypercortisolism.
CONCLUSIONS: Central serous chorioretinopathy is an uncommon manifestation of endogenous Cushing's syndrome. Since central serous chorioretinopathy has been associated with other hypercortisolemic states, we suggest that glucocorticoids may play a role in the development of this disease.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app